NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

First, to my knowledge, there has never been an official explanation of the enrollment halt or which regulator imposed it, only that it was lifted.

Second your description incorrectly calls the pause in enrollment a trial halt, which it was not as patients already enrolled continued to be treated.

That said, as an NWBO shareholder I have long believed that once the halt was lifted there should have been proper transparency and that vague characterizations about it complaining about ‘turning good news into bad’ have not been sufficient explanation for an event that harmed our investment here.

One could argue against my position and say that NWBO had to wait that until the trial was over to tell the whole truth about the enrollment halt in order to avoid compromising the trial.

However in April 2024, nearly two years after Top-Line Data was released, we should know and not have to speculate about what happened and why.

The continuing lack of transparency on the enrollment halt creates scope for critics like yourself to portray the enrollment halt in a negative light, to the detriment of shareholders.